Trials / Completed
CompletedNCT00212368
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Nobelpharma · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zinc acetate |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2005-08-01
- Completion
- 2005-12-01
- First posted
- 2005-09-21
- Last updated
- 2010-09-10
Source: ClinicalTrials.gov record NCT00212368. Inclusion in this directory is not an endorsement.